Yeah TaperT2, it took a nose dive from $22 to almost $2. News today turned it around. ARIAD Announces Positive Opinion by the European Medicines Agency on the Continued Availability of Iclusig in Patients with Leukaemias.
One day PLSB will do the same. Probably next year Q2 or Q3.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.